カテゴリー： Market Monitor Global, 世界, 医療/バイオ

神経膠腫治療の世界市場見通し2023年-2029年

◆英語タイトル：Glioma Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5590）◆商品コード：MMG23JU5590
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：123
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Glioma Treatment Market 調査レポートは次の情報を含め、グローバルにおけるの神経膠腫治療市場規模と予測を収録しています。・世界の神経膠腫治療市場：売上、2018年-2023年、2024年-2029年
・世界の神経膠腫治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の神経膠腫治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「化学薬品」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

神経膠腫治療のグローバル主要企業は、Sun Pharmaceutical、 Amgen、 Teva Pharmaceutical、 Bristol-Myers Squibb、 Pfizer、 Merck、 Eli Lilly、 F. Hoffmann-La Roche Ltd、 AbbVie、 Genentech、 BioMimetix、 Cipla、 Sigma-Aldrich、 Panacea Biotec、 Zydus Cadila、 Takeda Pharmaceuticals、 Boston Biomedical、 Ziopharm Oncology、 Celldex Therapeutics、 BERG、 Oncorus、 Agenus、 Deciphera Pharmaceuticals、 Karyopharm Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、神経膠腫治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の神経膠腫治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の神経膠腫治療市場：タイプ別市場シェア、2022年
・化学薬品、医薬品

世界の神経膠腫治療市場：用途別、2018年-2023年、2024年-2029年
世界の神経膠腫治療市場：用途別市場シェア、2022年
・病院、がん研究機関、診断センター、その他

世界の神経膠腫治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の神経膠腫治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における神経膠腫治療のグローバル売上、2018年-2023年
・主要企業における神経膠腫治療のグローバル売上シェア、2022年
・主要企業における神経膠腫治療のグローバル販売量、2018年-2023年
・主要企業における神経膠腫治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sun Pharmaceutical、 Amgen、 Teva Pharmaceutical、 Bristol-Myers Squibb、 Pfizer、 Merck、 Eli Lilly、 F. Hoffmann-La Roche Ltd、 AbbVie、 Genentech、 BioMimetix、 Cipla、 Sigma-Aldrich、 Panacea Biotec、 Zydus Cadila、 Takeda Pharmaceuticals、 Boston Biomedical、 Ziopharm Oncology、 Celldex Therapeutics、 BERG、 Oncorus、 Agenus、 Deciphera Pharmaceuticals、 Karyopharm Therapeutics

*************************************************************

・調査・分析レポートの概要
神経膠腫治療市場の定義
市場セグメント
世界の神経膠腫治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の神経膠腫治療市場規模
世界の神経膠腫治療市場規模：2022年 VS 2029年
世界の神経膠腫治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの神経膠腫治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の神経膠腫治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：化学薬品、医薬品
神経膠腫治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、がん研究機関、診断センター、その他
神経膠腫治療の用途別グローバル売上・予測

・地域別市場分析
地域別神経膠腫治療市場規模 2022年と2029年
地域別神経膠腫治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sun Pharmaceutical、 Amgen、 Teva Pharmaceutical、 Bristol-Myers Squibb、 Pfizer、 Merck、 Eli Lilly、 F. Hoffmann-La Roche Ltd、 AbbVie、 Genentech、 BioMimetix、 Cipla、 Sigma-Aldrich、 Panacea Biotec、 Zydus Cadila、 Takeda Pharmaceuticals、 Boston Biomedical、 Ziopharm Oncology、 Celldex Therapeutics、 BERG、 Oncorus、 Agenus、 Deciphera Pharmaceuticals、 Karyopharm Therapeutics
...

Chemotherapy is usually used in combination with radiation therapy to treat gliomas. The chemotherapy drug used most often to treat gliomas is temozolomide (Temodar), which is taken as a pill. Side effects of chemotherapy depend on the type and dose of drugs you receive.
This report aims to provide a comprehensive presentation of the global market for Glioma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glioma Treatment. This report contains market size and forecasts of Glioma Treatment in global, including the following market information:
Global Glioma Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Glioma Treatment Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Glioma Treatment companies in 2022 (%)
The global Glioma Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
ChemOthersapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Glioma Treatment include Sun Pharmaceutical, Amgen, Teva Pharmaceutical, Bristol-Myers Squibb, Pfizer, Merck, Eli Lilly, F. Hoffmann-La Roche Ltd and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glioma Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioma Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, by Type, 2022 (%)
ChemOthersapy
Drugs
Global Glioma Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Cancer Research Organizations
Diagnostic Centers
Others
Global Glioma Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glioma Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glioma Treatment revenues share in global market, 2022 (%)
Key companies Glioma Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Glioma Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharmaceutical
Amgen
Teva Pharmaceutical
Bristol-Myers Squibb
Pfizer
Merck
Eli Lilly
F. Hoffmann-La Roche Ltd
AbbVie
Genentech
BioMimetix
Cipla
Sigma-Aldrich
Panacea Biotec
Zydus Cadila
Takeda Pharmaceuticals
Boston Biomedical
Ziopharm Oncology
Celldex Therapeutics
BERG
Oncorus
Agenus
Deciphera Pharmaceuticals
Karyopharm Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glioma Treatment, market overview.
Chapter 2: Global Glioma Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Glioma Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glioma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glioma Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Glioma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glioma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glioma Treatment Overall Market Size
2.1 Global Glioma Treatment Market Size: 2022 VS 2029
2.2 Global Glioma Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glioma Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Glioma Treatment Players in Global Market
3.2 Top Global Glioma Treatment Companies Ranked by Revenue
3.3 Global Glioma Treatment Revenue by Companies
3.4 Global Glioma Treatment Sales by Companies
3.5 Global Glioma Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glioma Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glioma Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glioma Treatment Players in Global Market
3.8.1 List of Global Tier 1 Glioma Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Glioma Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Glioma Treatment Market Size Markets, 2022 & 2029
4.1.2 ChemOthersapy
4.1.3 Drugs
4.2 By Type – Global Glioma Treatment Revenue & Forecasts
4.2.1 By Type – Global Glioma Treatment Revenue, 2018-2023
4.2.2 By Type – Global Glioma Treatment Revenue, 2024-2029
4.2.3 By Type – Global Glioma Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Glioma Treatment Sales & Forecasts
4.3.1 By Type – Global Glioma Treatment Sales, 2018-2023
4.3.2 By Type – Global Glioma Treatment Sales, 2024-2029
4.3.3 By Type – Global Glioma Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Glioma Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Glioma Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Cancer Research Organizations
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application – Global Glioma Treatment Revenue & Forecasts
5.2.1 By Application – Global Glioma Treatment Revenue, 2018-2023
5.2.2 By Application – Global Glioma Treatment Revenue, 2024-2029
5.2.3 By Application – Global Glioma Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Glioma Treatment Sales & Forecasts
5.3.1 By Application – Global Glioma Treatment Sales, 2018-2023
5.3.2 By Application – Global Glioma Treatment Sales, 2024-2029
5.3.3 By Application – Global Glioma Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Glioma Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Glioma Treatment Market Size, 2022 & 2029
6.2 By Region – Global Glioma Treatment Revenue & Forecasts
6.2.1 By Region – Global Glioma Treatment Revenue, 2018-2023
6.2.2 By Region – Global Glioma Treatment Revenue, 2024-2029
6.2.3 By Region – Global Glioma Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Glioma Treatment Sales & Forecasts
6.3.1 By Region – Global Glioma Treatment Sales, 2018-2023
6.3.2 By Region – Global Glioma Treatment Sales, 2024-2029
6.3.3 By Region – Global Glioma Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Glioma Treatment Revenue, 2018-2029
6.4.2 By Country – North America Glioma Treatment Sales, 2018-2029
6.4.3 US Glioma Treatment Market Size, 2018-2029
6.4.4 Canada Glioma Treatment Market Size, 2018-2029
6.4.5 Mexico Glioma Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Glioma Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Glioma Treatment Sales, 2018-2029
6.5.3 Germany Glioma Treatment Market Size, 2018-2029
6.5.4 France Glioma Treatment Market Size, 2018-2029
6.5.5 U.K. Glioma Treatment Market Size, 2018-2029
6.5.6 Italy Glioma Treatment Market Size, 2018-2029
6.5.7 Russia Glioma Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Glioma Treatment Market Size, 2018-2029
6.5.9 Benelux Glioma Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Glioma Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Glioma Treatment Sales, 2018-2029
6.6.3 China Glioma Treatment Market Size, 2018-2029
6.6.4 Japan Glioma Treatment Market Size, 2018-2029
6.6.5 South Korea Glioma Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Glioma Treatment Market Size, 2018-2029
6.6.7 India Glioma Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Glioma Treatment Revenue, 2018-2029
6.7.2 By Country – South America Glioma Treatment Sales, 2018-2029
6.7.3 Brazil Glioma Treatment Market Size, 2018-2029
6.7.4 Argentina Glioma Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Glioma Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Glioma Treatment Sales, 2018-2029
6.8.3 Turkey Glioma Treatment Market Size, 2018-2029
6.8.4 Israel Glioma Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Glioma Treatment Market Size, 2018-2029
6.8.6 UAE Glioma Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sun Pharmaceutical
7.1.1 Sun Pharmaceutical Company Summary
7.1.2 Sun Pharmaceutical Business Overview
7.1.3 Sun Pharmaceutical Glioma Treatment Major Product Offerings
7.1.4 Sun Pharmaceutical Glioma Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Sun Pharmaceutical Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Glioma Treatment Major Product Offerings
7.2.4 Amgen Glioma Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Company Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Glioma Treatment Major Product Offerings
7.3.4 Teva Pharmaceutical Glioma Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Teva Pharmaceutical Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Glioma Treatment Major Product Offerings
7.4.4 Bristol-Myers Squibb Glioma Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Glioma Treatment Major Product Offerings
7.5.4 Pfizer Glioma Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Glioma Treatment Major Product Offerings
7.6.4 Merck Glioma Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Glioma Treatment Major Product Offerings
7.7.4 Eli Lilly Glioma Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Company Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Glioma Treatment Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Glioma Treatment Sales and Revenue in Global (2018-2023)
7.8.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Glioma Treatment Major Product Offerings
7.9.4 AbbVie Glioma Treatment Sales and Revenue in Global (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Genentech
7.10.1 Genentech Company Summary
7.10.2 Genentech Business Overview
7.10.3 Genentech Glioma Treatment Major Product Offerings
7.10.4 Genentech Glioma Treatment Sales and Revenue in Global (2018-2023)
7.10.5 Genentech Key News & Latest Developments
7.11 BioMimetix
7.11.1 BioMimetix Company Summary
7.11.2 BioMimetix Glioma Treatment Business Overview
7.11.3 BioMimetix Glioma Treatment Major Product Offerings
7.11.4 BioMimetix Glioma Treatment Sales and Revenue in Global (2018-2023)
7.11.5 BioMimetix Key News & Latest Developments
7.12 Cipla
7.12.1 Cipla Company Summary
7.12.2 Cipla Glioma Treatment Business Overview
7.12.3 Cipla Glioma Treatment Major Product Offerings
7.12.4 Cipla Glioma Treatment Sales and Revenue in Global (2018-2023)
7.12.5 Cipla Key News & Latest Developments
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Company Summary
7.13.2 Sigma-Aldrich Glioma Treatment Business Overview
7.13.3 Sigma-Aldrich Glioma Treatment Major Product Offerings
7.13.4 Sigma-Aldrich Glioma Treatment Sales and Revenue in Global (2018-2023)
7.13.5 Sigma-Aldrich Key News & Latest Developments
7.14 Panacea Biotec
7.14.1 Panacea Biotec Company Summary
7.14.2 Panacea Biotec Business Overview
7.14.3 Panacea Biotec Glioma Treatment Major Product Offerings
7.14.4 Panacea Biotec Glioma Treatment Sales and Revenue in Global (2018-2023)
7.14.5 Panacea Biotec Key News & Latest Developments
7.15 Zydus Cadila
7.15.1 Zydus Cadila Company Summary
7.15.2 Zydus Cadila Business Overview
7.15.3 Zydus Cadila Glioma Treatment Major Product Offerings
7.15.4 Zydus Cadila Glioma Treatment Sales and Revenue in Global (2018-2023)
7.15.5 Zydus Cadila Key News & Latest Developments
7.16 Takeda Pharmaceuticals
7.16.1 Takeda Pharmaceuticals Company Summary
7.16.2 Takeda Pharmaceuticals Business Overview
7.16.3 Takeda Pharmaceuticals Glioma Treatment Major Product Offerings
7.16.4 Takeda Pharmaceuticals Glioma Treatment Sales and Revenue in Global (2018-2023)
7.16.5 Takeda Pharmaceuticals Key News & Latest Developments
7.17 Boston Biomedical
7.17.1 Boston Biomedical Company Summary
7.17.2 Boston Biomedical Business Overview
7.17.3 Boston Biomedical Glioma Treatment Major Product Offerings
7.17.4 Boston Biomedical Glioma Treatment Sales and Revenue in Global (2018-2023)
7.17.5 Boston Biomedical Key News & Latest Developments
7.18 Ziopharm Oncology
7.18.1 Ziopharm Oncology Company Summary
7.18.2 Ziopharm Oncology Business Overview
7.18.3 Ziopharm Oncology Glioma Treatment Major Product Offerings
7.18.4 Ziopharm Oncology Glioma Treatment Sales and Revenue in Global (2018-2023)
7.18.5 Ziopharm Oncology Key News & Latest Developments
7.19 Celldex Therapeutics
7.19.1 Celldex Therapeutics Company Summary
7.19.2 Celldex Therapeutics Business Overview
7.19.3 Celldex Therapeutics Glioma Treatment Major Product Offerings
7.19.4 Celldex Therapeutics Glioma Treatment Sales and Revenue in Global (2018-2023)
7.19.5 Celldex Therapeutics Key News & Latest Developments
7.20 BERG
7.20.1 BERG Company Summary
7.20.2 BERG Business Overview
7.20.3 BERG Glioma Treatment Major Product Offerings
7.20.4 BERG Glioma Treatment Sales and Revenue in Global (2018-2023)
7.20.5 BERG Key News & Latest Developments
7.21 Oncorus
7.21.1 Oncorus Company Summary
7.21.2 Oncorus Business Overview
7.21.3 Oncorus Glioma Treatment Major Product Offerings
7.21.4 Oncorus Glioma Treatment Sales and Revenue in Global (2018-2023)
7.21.5 Oncorus Key News & Latest Developments
7.22 Agenus
7.22.1 Agenus Company Summary
7.22.2 Agenus Business Overview
7.22.3 Agenus Glioma Treatment Major Product Offerings
7.22.4 Agenus Glioma Treatment Sales and Revenue in Global (2018-2023)
7.22.5 Agenus Key News & Latest Developments
7.23 Deciphera Pharmaceuticals
7.23.1 Deciphera Pharmaceuticals Company Summary
7.23.2 Deciphera Pharmaceuticals Business Overview
7.23.3 Deciphera Pharmaceuticals Glioma Treatment Major Product Offerings
7.23.4 Deciphera Pharmaceuticals Glioma Treatment Sales and Revenue in Global (2018-2023)
7.23.5 Deciphera Pharmaceuticals Key News & Latest Developments
7.24 Karyopharm Therapeutics
7.24.1 Karyopharm Therapeutics Company Summary
7.24.2 Karyopharm Therapeutics Business Overview
7.24.3 Karyopharm Therapeutics Glioma Treatment Major Product Offerings
7.24.4 Karyopharm Therapeutics Glioma Treatment Sales and Revenue in Global (2018-2023)
7.24.5 Karyopharm Therapeutics Key News & Latest Developments
8 Global Glioma Treatment Production Capacity, Analysis
8.1 Global Glioma Treatment Production Capacity, 2018-2029
8.2 Glioma Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Glioma Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glioma Treatment Supply Chain Analysis
10.1 Glioma Treatment Industry Value Chain
10.2 Glioma Treatment Upstream Market
10.3 Glioma Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glioma Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Glioma Treatment in Global Market
Table 2. Top Glioma Treatment Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Glioma Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Glioma Treatment Revenue Share by Companies, 2018-2023
Table 5. Global Glioma Treatment Sales by Companies, (K Units), 2018-2023
Table 6. Global Glioma Treatment Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Glioma Treatment Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Glioma Treatment Product Type
Table 9. List of Global Tier 1 Glioma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glioma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Glioma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Glioma Treatment Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Glioma Treatment Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Glioma Treatment Sales (K Units), 2018-2023
Table 15. By Type - Global Glioma Treatment Sales (K Units), 2024-2029
Table 16. By Application – Global Glioma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Glioma Treatment Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Glioma Treatment Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Glioma Treatment Sales (K Units), 2018-2023
Table 20. By Application - Global Glioma Treatment Sales (K Units), 2024-2029
Table 21. By Region – Global Glioma Treatment Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Glioma Treatment Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Glioma Treatment Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Glioma Treatment Sales (K Units), 2018-2023
Table 25. By Region - Global Glioma Treatment Sales (K Units), 2024-2029
Table 26. By Country - North America Glioma Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Glioma Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Glioma Treatment Sales, (K Units), 2018-2023
Table 29. By Country - North America Glioma Treatment Sales, (K Units), 2024-2029
Table 30. By Country - Europe Glioma Treatment Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Glioma Treatment Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Glioma Treatment Sales, (K Units), 2018-2023
Table 33. By Country - Europe Glioma Treatment Sales, (K Units), 2024-2029
Table 34. By Region - Asia Glioma Treatment Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Glioma Treatment Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Glioma Treatment Sales, (K Units), 2018-2023
Table 37. By Region - Asia Glioma Treatment Sales, (K Units), 2024-2029
Table 38. By Country - South America Glioma Treatment Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Glioma Treatment Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Glioma Treatment Sales, (K Units), 2018-2023
Table 41. By Country - South America Glioma Treatment Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Glioma Treatment Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Glioma Treatment Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Glioma Treatment Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Glioma Treatment Sales, (K Units), 2024-2029
Table 46. Sun Pharmaceutical Company Summary
Table 47. Sun Pharmaceutical Glioma Treatment Product Offerings
Table 48. Sun Pharmaceutical Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sun Pharmaceutical Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Glioma Treatment Product Offerings
Table 52. Amgen Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Teva Pharmaceutical Company Summary
Table 55. Teva Pharmaceutical Glioma Treatment Product Offerings
Table 56. Teva Pharmaceutical Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Teva Pharmaceutical Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Glioma Treatment Product Offerings
Table 60. Bristol-Myers Squibb Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Glioma Treatment Product Offerings
Table 64. Pfizer Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Glioma Treatment Product Offerings
Table 68. Merck Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Merck Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Glioma Treatment Product Offerings
Table 72. Eli Lilly Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. F. Hoffmann-La Roche Ltd Company Summary
Table 75. F. Hoffmann-La Roche Ltd Glioma Treatment Product Offerings
Table 76. F. Hoffmann-La Roche Ltd Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 78. AbbVie Company Summary
Table 79. AbbVie Glioma Treatment Product Offerings
Table 80. AbbVie Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. AbbVie Key News & Latest Developments
Table 82. Genentech Company Summary
Table 83. Genentech Glioma Treatment Product Offerings
Table 84. Genentech Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Genentech Key News & Latest Developments
Table 86. BioMimetix Company Summary
Table 87. BioMimetix Glioma Treatment Product Offerings
Table 88. BioMimetix Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. BioMimetix Key News & Latest Developments
Table 90. Cipla Company Summary
Table 91. Cipla Glioma Treatment Product Offerings
Table 92. Cipla Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Cipla Key News & Latest Developments
Table 94. Sigma-Aldrich Company Summary
Table 95. Sigma-Aldrich Glioma Treatment Product Offerings
Table 96. Sigma-Aldrich Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Sigma-Aldrich Key News & Latest Developments
Table 98. Panacea Biotec Company Summary
Table 99. Panacea Biotec Glioma Treatment Product Offerings
Table 100. Panacea Biotec Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Panacea Biotec Key News & Latest Developments
Table 102. Zydus Cadila Company Summary
Table 103. Zydus Cadila Glioma Treatment Product Offerings
Table 104. Zydus Cadila Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Zydus Cadila Key News & Latest Developments
Table 106. Takeda Pharmaceuticals Company Summary
Table 107. Takeda Pharmaceuticals Glioma Treatment Product Offerings
Table 108. Takeda Pharmaceuticals Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Takeda Pharmaceuticals Key News & Latest Developments
Table 110. Boston Biomedical Company Summary
Table 111. Boston Biomedical Glioma Treatment Product Offerings
Table 112. Boston Biomedical Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Boston Biomedical Key News & Latest Developments
Table 114. Ziopharm Oncology Company Summary
Table 115. Ziopharm Oncology Glioma Treatment Product Offerings
Table 116. Ziopharm Oncology Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Ziopharm Oncology Key News & Latest Developments
Table 118. Celldex Therapeutics Company Summary
Table 119. Celldex Therapeutics Glioma Treatment Product Offerings
Table 120. Celldex Therapeutics Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Celldex Therapeutics Key News & Latest Developments
Table 122. BERG Company Summary
Table 123. BERG Glioma Treatment Product Offerings
Table 124. BERG Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. BERG Key News & Latest Developments
Table 126. Oncorus Company Summary
Table 127. Oncorus Glioma Treatment Product Offerings
Table 128. Oncorus Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 129. Oncorus Key News & Latest Developments
Table 130. Agenus Company Summary
Table 131. Agenus Glioma Treatment Product Offerings
Table 132. Agenus Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 133. Agenus Key News & Latest Developments
Table 134. Deciphera Pharmaceuticals Company Summary
Table 135. Deciphera Pharmaceuticals Glioma Treatment Product Offerings
Table 136. Deciphera Pharmaceuticals Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 137. Deciphera Pharmaceuticals Key News & Latest Developments
Table 138. Karyopharm Therapeutics Company Summary
Table 139. Karyopharm Therapeutics Glioma Treatment Product Offerings
Table 140. Karyopharm Therapeutics Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 141. Karyopharm Therapeutics Key News & Latest Developments
Table 142. Glioma Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 143. Global Glioma Treatment Capacity Market Share of Key Manufacturers, 2021-2023
Table 144. Global Glioma Treatment Production by Region, 2018-2023 (K Units)
Table 145. Global Glioma Treatment Production by Region, 2024-2029 (K Units)
Table 146. Glioma Treatment Market Opportunities & Trends in Global Market
Table 147. Glioma Treatment Market Drivers in Global Market
Table 148. Glioma Treatment Market Restraints in Global Market
Table 149. Glioma Treatment Raw Materials
Table 150. Glioma Treatment Raw Materials Suppliers in Global Market
Table 151. Typical Glioma Treatment Downstream
Table 152. Glioma Treatment Downstream Clients in Global Market
Table 153. Glioma Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Glioma Treatment Segment by Type in 2022
Figure 2. Glioma Treatment Segment by Application in 2022
Figure 3. Global Glioma Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Glioma Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Glioma Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. Glioma Treatment Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glioma Treatment Revenue in 2022
Figure 9. By Type - Global Glioma Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Glioma Treatment Revenue Market Share, 2018-2029
Figure 11. By Type - Global Glioma Treatment Sales Market Share, 2018-2029
Figure 12. By Type - Global Glioma Treatment Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Glioma Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Glioma Treatment Revenue Market Share, 2018-2029
Figure 15. By Application - Global Glioma Treatment Sales Market Share, 2018-2029
Figure 16. By Application - Global Glioma Treatment Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Glioma Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Glioma Treatment Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Glioma Treatment Revenue Market Share, 2018-2029
Figure 20. By Region - Global Glioma Treatment Sales Market Share, 2018-2029
Figure 21. By Country - North America Glioma Treatment Revenue Market Share, 2018-2029
Figure 22. By Country - North America Glioma Treatment Sales Market Share, 2018-2029
Figure 23. US Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Glioma Treatment Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Glioma Treatment Sales Market Share, 2018-2029
Figure 28. Germany Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. France Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Glioma Treatment Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Glioma Treatment Sales Market Share, 2018-2029
Figure 37. China Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. India Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Glioma Treatment Revenue Market Share, 2018-2029
Figure 43. By Country - South America Glioma Treatment Sales Market Share, 2018-2029
Figure 44. Brazil Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Glioma Treatment Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Glioma Treatment Sales Market Share, 2018-2029
Figure 48. Turkey Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Glioma Treatment Revenue, (US$, Mn), 2018-2029
Figure 52. Global Glioma Treatment Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Glioma Treatment by Region, 2022 VS 2029
Figure 54. Glioma Treatment Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 神経膠腫治療の世界市場見通し2023年-2029年(Glioma Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 低悪性度神経膠腫用治療のグローバル市場予測2023-2029
  • 世界の成人悪性神経膠腫治療市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆